Virtuoso Surgical receives a grant from the National Heart, Lung, and Blood Institute to further study the use of Virtuoso's technology to treat central airway obstructions.
Virtuoso publishes a collaboration with surgeons at Vanderbilt University Medical center estabilishing the feasibility of using Virtuoso's technology to treat central airway obstructions secondary to lung cancer. Virtuoso's technology was shown to reduce force on the patient's head and neck and is likely to reduce complications from the procedure. The full article can be viewed here.
MedTech Strategist names Virtuoso a "Startup to Watch" in its January issue. The article can be found here.
Virtuoso founder Robert Webster visits the 2018 Congress of Neurological Surgeons to present neurosurgical applications of the Virtuoso technology.
Virtuoso founder Mark Pickrell visits MedTech Strategist to present Virtuoso's technology to potential investors.
Virtuoso founder Duke Herrell visits the 2018 World Congress of Endourology to present an update on the Virtuoso technology for urologic applications.
Robert Webster and Duke Herrell visit the American Urologic Association's Annual Meeting to present about Virtuoso's potential treatment for benign prostatic hyperplasia.
Virtuoso Surgical receives an STTR award from the National Heart, Lung, and Blood Institute. The award will fund application of Virtuoso's technology to treat central airway obstructions.
Virtuoso Surgical receives an SBIR Matching Grant Award from Launch Tennessee. The State award will accelerate progress and promote growth in Tennessee.
Virtuoso Surgical receives a Notice of Award from the National Institute of Biomedical Imaging and Bioengineering. The NIH award is expected to fund prototype development, testing, and regulatory approval efforts for a two-year period.
Virtuoso Surgical begins formal operations, opening its engineering offices and engineering laboratory in Nashville, Tennessee for development of its endoscopic surgical device.
Virtuoso Surgical, Inc. is incorporated by Dr. Webster, Dr. Herrell, Dr. Hendrick, and Mark Pickrell to commercialize a surgical device using concentric tube technology.